Treatment and outcomes for patients with bacteremic pneumococcal pneumonia

Medicine
Catherine M BerjohnJoshua P Metlay

Abstract

Delayed time to antibiotic administration has been linked with higher mortality for patients with community-acquired pneumonia, but the impact of antibiotic resistance on clinical outcomes has been controversial. In the current study we assess the combined impact of antibiotic resistance and antibiotic timing on outcomes, including inhospital mortality, complications, length of stay, and time to stability, for patients hospitalized with community-acquired bacteremic pneumococcal pneumonia. We conducted a retrospective cohort study in 43 hospitals in the Southeastern Pennsylvania region from 2001 to 2004. Eligible adult patients had pneumococcal bacteremia and radiographic evidence of pneumonia. Outcomes were assessed based on medical record review. Multivariable regression was used to adjust for severity of illness and sequentially assess the impact of antibiotic resistance and time to active antibiotic therapy. The overall inhospital mortality was 10%. Overall, levels of macrolide, cephalosporin, and fluoroquinolone resistance were low and did not adversely impact the time to administration of active antibiotic therapy. Receipt of at least 1 active antibiotic within 4 hours was associated with reduced mortality (odds ratio [OR...Continue Reading

References

Mar 1, 1985·Reviews of Infectious Diseases·L A BurmanB Trollfors
Feb 25, 1983·JAMA : the Journal of the American Medical Association·E W HookD R Schaberg
Aug 1, 1993·Journal of Clinical Microbiology·U B Sørensen
Aug 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B AfessaW R Frederick
Jan 23, 1997·The New England Journal of Medicine·M J FineW N Kapoor
Dec 24, 1997·JAMA : the Journal of the American Medical Association·T P MeehanJ M Fine
May 26, 1998·JAMA : the Journal of the American Medical Association·E A HalmDaniel E Singer
Aug 18, 1999·The American Journal of Medicine·M A Mufson, R J Stanek
Aug 15, 2000·Medicine·Daniel M MusherE Solomon
Nov 13, 2002·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Joshua P Metlay, Daniel E Singer
May 2, 2003·The New England Journal of Medicine·Cynthia G WhitneyActive Bacterial Core Surveillance of the Emerging Infections Program Network
May 1, 1964·Annals of Internal Medicine·Robert Austrian, J GOLD
Nov 14, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lionel A MandellInfectious Diseases Society of America
Sep 13, 2006·Emerging Infectious Diseases·Joshua P MetlayPaul H Edelstein
Dec 14, 2006·JAMA : the Journal of the American Medical Association·Rachel M Werner, Eric T Bradlow
Feb 6, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lionel A MandellAmerican Thoracic Society
Feb 14, 2007·Antimicrobial Agents and Chemotherapy·Steven J Projan
Nov 9, 2007·Joint Commission Journal on Quality and Patient Safety·Jesse M PinesJoshua P Metlay

Citations

Oct 30, 2010·The Pediatric Infectious Disease Journal·Jennifer A MuszynskiMark W Hall
Jun 15, 2011·Clinical Chemistry and Laboratory Medicine : CCLM·Sabine C A MeijvisEwoudt M W van de Garde
Feb 1, 2011·Drugs·Charles Feldman, Ronald Anderson
Mar 19, 2011·Clinical Medicine : Journal of the Royal College of Physicians of London·Thomas BewickWei Shen Lim
Jan 22, 2014·BMC Infectious Diseases·Carl van Walraven, Jenna Wong
Oct 15, 2013·Medicina clínica·Maria Teresa Pérez-RodríguezMaximiliano Álvarez-fernández
Mar 4, 2015·Open Forum Infectious Diseases·Mathieu BlotLionel Piroth
Jan 21, 2010·Scandinavian Journal of Infectious Diseases·Jose Garnacho-MonteroJavier Aznar-Martín
May 15, 2012·Diagnostic Microbiology and Infectious Disease·Jose Garnacho-MonteroCarmen Garnacho-Montero
Mar 14, 2012·Enfermedades infecciosas y microbiología clínica·Juan González-CastilloAgustín Julián-Jiménez
Nov 2, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M WoodheadJoint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases
Nov 2, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M WoodheadJoint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases
Aug 7, 2014·BMC Pulmonary Medicine·Alberto CapelasteguiPedro P España
Mar 23, 2017·The Journal of Infection·Ronald Anderson, Charles Feldman
Aug 18, 2018·Expert Review of Anti-infective Therapy·Jose Garnacho-MonteroIgnacio Martín-Loeches
Jul 1, 2010·Expert Review of Anti-infective Therapy·Jesús Rodríguez-BañoJuan Gálvez-Acebal
Jul 21, 2009·Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia·Ricardo de Amorim CorrêaComissão de Infecções Respiratórias e Micoses - Sociedade Brasileira de Pneumologia e Tisiologia
Feb 9, 2017·BMC Infectious Diseases·Kim O GradelDanish Collaborative Bacteraemia Network (DACOBAN)

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.